Privia Health Group, Inc.·4

Mar 10, 4:02 PM ET

Mehrotra Parth 4

Research Summary

AI-generated summary

Updated

Privia Health (PRVA) CEO Parth Mehrotra Sells Shares

What Happened Parth Mehrotra, CEO of Privia Health Group, sold a total of 63,439 shares between March 6 and March 9, 2026 for an aggregate proceeds of approximately $1,456,240. Individual reported transactions:

  • 21,440 shares on 2026-03-06 at $23.15 ($496,336)
  • 21,915 shares on 2026-03-09 at a weighted $22.84 ($500,539)
  • 1,219 shares on 2026-03-09 at a weighted $23.37 ($28,488)
  • 18,865 shares on 2026-03-09 at a weighted $22.84 ($430,877)

These were sales (not purchases); sales are often routine (e.g., tax-withholding or pre-set plans) rather than an explicit bullish signal.

Key Details

  • Dates/prices: Mar 6 (21,440 @ $23.15); Mar 9 (21,915 @ $22.84; 1,219 @ $23.37; 18,865 @ $22.84). Overall weighted avg ~ $22.95/share.
  • Total shares sold: 63,439; total proceeds: ~$1,456,240.
  • Shares owned after transaction: Not specified in the information provided.
  • Footnotes: Some shares were sold to satisfy tax withholding on RSU vesting (sell-to-cover). Other sales were executed under a Rule 10b5-1 trading plan. Reported weighted-price ranges: $22.35–$23.34 and $23.35–$23.41; the filer can provide a full breakdown on request.
  • Filing: Report filed March 10, 2026; timing appears consistent with normal Form 4 reporting windows.

Context These transactions include sell-to-cover activity related to restricted stock unit vesting and sales under a pre-established 10b5-1 plan. Such transactions are commonly administrative or tax-driven and do not necessarily reflect a change in the insider’s view of the company. If you want a full per-trade price breakdown or the insider’s post-sale holdings, the filer or the company can provide that information on request.

Loading document...